PortfoliosLab logo

Bristol-Myers Squibb Company (BMY)

Equity · Currency in USD
Sector
Healthcare
Industry
Drug Manufacturers—General
ISIN
US1101221083
CUSIP
110122108

BMYPrice Chart


Chart placeholderClick Calculate to get results

BMYPerformance

The chart shows the growth of $10,000 invested in Bristol-Myers Squibb Company on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $32,288 for a total return of roughly 222.88%. All prices are adjusted for splits and dividends.


BMY (Bristol-Myers Squibb Company)
Benchmark (S&P 500)

BMYReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-2.94%0.43%
6M-12.63%9.37%
YTD-6.72%22.33%
1Y-7.19%26.59%
5Y2.86%15.74%
10Y9.38%14.46%

BMYMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

BMYSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bristol-Myers Squibb Company Sharpe ratio is -0.40. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


BMY (Bristol-Myers Squibb Company)
Benchmark (S&P 500)

BMYDividends

Bristol-Myers Squibb Company granted a 3.47% dividend yield in the last twelve months, as of Nov 27, 2021. The annual payout for that period amounted to $1.96 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$1.96$2.29$1.64$1.60$1.56$1.14$1.49$1.45$1.76$1.36$1.32$0.96

Dividend yield

3.47%3.69%2.55%3.08%2.55%1.95%2.17%2.46%3.31%4.17%3.75%3.63%

BMYDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


BMY (Bristol-Myers Squibb Company)
Benchmark (S&P 500)

BMYWorst Drawdowns

The table below shows the maximum drawdowns of the Bristol-Myers Squibb Company. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bristol-Myers Squibb Company is 39.30%, recorded on Jul 22, 2019. It took 462 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-39.3%Jul 15, 2016759Jul 22, 2019462May 20, 20211221
-18.21%Jul 15, 201538Sep 4, 201570Dec 15, 2015108
-17.83%Aug 4, 202160Oct 27, 2021
-17.12%Mar 6, 201466Jun 9, 2014101Oct 30, 2014167
-16.73%Apr 5, 201044Jun 4, 201046Aug 10, 201090
-16.29%Dec 17, 201531Feb 2, 201655Apr 21, 201686
-13.91%Jul 20, 201282Nov 15, 201246Jan 24, 2013128
-13.6%Jan 13, 201417Feb 5, 201418Mar 4, 201435
-12.66%May 29, 201360Aug 21, 201320Sep 19, 201380
-10.76%Jul 22, 201112Aug 8, 201117Aug 31, 201129

BMYVolatility Chart

Current Bristol-Myers Squibb Company volatility is 14.92%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


BMY (Bristol-Myers Squibb Company)
Benchmark (S&P 500)

Portfolios with Bristol-Myers Squibb Company


Loading data...

More Tools for Bristol-Myers Squibb Company